| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-TNC mAbs [Tenatumomab Biosimilar] (MABL-5304) | MABL-5304 | ELISA, FACS, Functional assay, in vivo binding | G2b, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Teneliximab Biosimilar] (MABL-5305) | MABL-5305 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E mAbs [Teplizumab Biosimilar] (MABL-5306) | MABL-5306 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Tagitanlimab Biosimilar] (MABL-5278) | MABL-5278 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL3RA/CD123 mAbs [Talacotuzumab Biosimilar] (MABL-5279) | MABL-5279 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IgE mAbs [Talizumab Biosimilar] (MABL-5280) | MABL-5280 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GPRC5D;CD3E mAbs [Talquetamab Biosimilar] (MABL-5281) | MABL-5281 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Lambda |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Tamgiblimab Biosimilar] (MABL-5282) | MABL-5282 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-DPEP3 mAbs [Tamrintamab Biosimilar] (MABL-5283) | MABL-5283 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD52 mAbs [Tamtuvetmab Biosimilar] (MABL-5284) | MABL-5284 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-NGFB mAbs [Tanezumab Biosimilar] (MABL-5285) | MABL-5285 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-C1q mAbs [Tanruprubart Biosimilar] (MABL-5286) | MABL-5286 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-VEGFA mAbs [Tarcocimab Biosimilar] (MABL-5287) | MABL-5287 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NOTCH2 and NOTCH3 mAbs [Tarextumab Biosimilar] (MABL-5288) | MABL-5288 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-DLL3;CD3E mAbs [Tarlatamab Biosimilar] (MABL-5289) | MABL-5289 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-ALB;CFP mAbs [Tarperprumig Biosimilar] (MABL-5290) | MABL-5290 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-TNFSF4/CD134/CD252/OX40L mAbs [Tavolimab Biosimilar] (MABL-5291) | MABL-5291 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Tazlestobart Biosimilar] (MABL-5292) | MABL-5292 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E mAbs [Tebentafusp Biosimilar] (MABL-5293) | MABL-5293 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-Respiratory Syncytial Virus Glycoprotein F mAbs [Suptavumab Biosimilar] (MABL-5262) | MABL-5262 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
